Top Pharmaceuticals companies in Sweden by EBITDA

This ranking features the top 102 Pharmaceuticals companies in Sweden ranked by EBITDA, totalling a EBITDA of USD 4.88 B, for January 15, 2025.

Sweden

Pharmaceuticals

#	Name	EBITDA	Reported Date	Stock Price	Change	Country
1	Essity AB (publ) 1 ESSITY-B.ST	USD 2.06 B	Dec. 31, 2023	USD 26.00	1.16%	Sweden
2	Swedish Orphan Biovitrum AB (publ) 2 SOBI.ST	USD 714.00 M	Dec. 31, 2023	USD 28.64	0.87%	Sweden
3	Lifco AB (publ) 3 LIFCO-B.ST	USD 621.02 M	Dec. 31, 2023	USD 28.08	0.23%	Sweden
4	Getinge AB (publ) 4 GETI-B.ST	USD 585.19 M	Dec. 31, 2023	USD 16.63	0.49%	Sweden
5	Elekta AB (publ) 5 EKTA-B.ST	USD 297.84 M	April 30, 2024	USD 5.39	-0.39%	Sweden
6	Medicover AB (publ) 6 MCOV-B.ST	USD 284.11 M	Dec. 31, 2023	USD 17.18	2.59%	Sweden
7	Arjo AB (publ) 7 ARJO-B.ST	USD 193.55 M	Dec. 31, 2023	USD 3.30	3.88%	Sweden
8	AddLife AB (publ) 8 ALIF-B.ST	USD 152.59 M	Dec. 31, 2023	USD 12.08	1.50%	Sweden
9	Nolato AB (publ) 9 NOLA-B.ST	USD 126.53 M	Dec. 31, 2023	USD 4.73	3.81%	Sweden
10	Vimian Group AB (publ) 10 VIMIAN.ST	USD 76.36 M	Dec. 31, 2023	USD 3.41	3.24%	Sweden
11	Linc AB 11 LINC.ST	USD 65.74 M	Dec. 31, 2023	USD 8.02	0.46%	Sweden
12	Sectra AB (publ) 12 SECT-B.ST	USD 55.66 M	April 30, 2024	USD 22.17	-0.20%	Sweden
13	Camurus AB (publ) 13 CAMX.ST	USD 55.52 M	Dec. 31, 2023	USD 51.72	-0.10%	Sweden
14	BioGaia AB (publ) 14 BIOG-B.ST	USD 48.85 M	Dec. 31, 2023	USD 9.75	-0.95%	Sweden
15	Swedencare AB (publ) 15 SECARE.ST	USD 47.77 M	Dec. 31, 2023	USD 3.87	2.52%	Sweden
16	Biotage AB (publ) 16 BIOT.ST	USD 42.64 M	Dec. 31, 2023	USD 11.98	-2.51%	Sweden
17	ADDvise Group AB (publ) 17 ADDV-B.ST	USD 41.59 M	Dec. 31, 2023	USD 0.28	0.36%	Sweden
18	RaySearch Laboratories AB (publ) 18 RAY-B.ST	USD 40.07 M	Dec. 31, 2023	USD 20.58	0.68%	Sweden
19	MedCap AB (publ) 19 MCAP.ST	USD 33.75 M	Dec. 31, 2023	USD 52.21	-0.68%	Sweden
20	BioArctic AB (publ) 20 BIOA-B.ST	USD 29.15 M	Dec. 31, 2023	USD 17.87	3.09%	Sweden
21	Teqnion AB (publ) 21 TEQ.ST	USD 22.66 M	Dec. 31, 2023	USD 14.61	2.17%	Sweden
22	CellaVision AB (publ) 22 CEVI.ST	USD 20.46 M	Dec. 31, 2023	USD 18.76	3.89%	Sweden
23	Xvivo Perfusion AB (publ) 23 XVIVO.ST	USD 12.49 M	Dec. 31, 2023	USD 42.37	0.78%	Sweden
24	Probi AB (publ) 24 PROB.ST	USD 11.41 M	Dec. 31, 2023	USD 31.10	0.68%	Sweden
25	Intellego Technologies AB 25 INT.ST	USD 7.63 M	Dec. 31, 2023	USD 2.97	0.98%	Sweden
26	Boule Diagnostics AB (publ) 26 BOUL.ST	USD 6.51 M	Dec. 31, 2023	USD 0.89	14.73%	Sweden
27	Genovis AB (publ.) 27 GENO.ST	USD 6.37 M	Dec. 31, 2023	USD 2.09	-2.04%	Sweden
28	Sleep Cycle AB (publ) 28 SLEEP.ST	USD 6.32 M	Dec. 31, 2023	USD 3.33	0.41%	Sweden
29	Stille AB 29 STIL.ST	USD 5.53 M	Dec. 31, 2023	USD 19.07	4.08%	Sweden
30	C-Rad AB (publ) 30 CRAD-B.ST	USD 4.83 M	Dec. 31, 2023	USD 2.57	-0.02%	Sweden
31	Magle Chemoswed Holding AB (publ) 31 MAGLE.ST	USD 3.10 M	Dec. 31, 2023	USD 3.31	2.33%	Sweden
32	Bonesupport Holding AB (publ) 32 BONEX.ST	USD 2.86 M	Dec. 31, 2023	USD 32.97	-0.61%	Sweden
33	Mentice AB (publ) 33 MNTC.ST	USD 2.85 M	Dec. 31, 2023	USD 2.19	0.18%	Sweden
34	Serstech AB 34 SERT.ST	USD 1.28 M	Dec. 31, 2023	USD 0.12	3.82%	Sweden
35	Infant Bacterial Therapeutics AB (publ) 35 IBT-B.ST	USD 1.14 M	Dec. 31, 2023	USD 4.07	-5.72%	Sweden
36	Integrum AB (publ) 36 INTEG-B.ST	USD 792.92 K	April 30, 2024	USD 1.60	-0.43%	Sweden
37	OncoZenge AB (publ) 37 ONCOZ.ST	USD 717.15 K	Dec. 31, 2023	USD 0.45	23.08%	Sweden
38	Arcoma AB 38 ARCOMA.ST	USD 603.35 K	Dec. 31, 2023	USD 0.97	-2.02%	Sweden
39	Kontigo Care AB (publ) 39 KONT.ST	USD 177.07 K	Dec. 31, 2023	USD 0.23	-0.87%	Sweden
40	Gasporox AB (publ) 40 GPX.ST	USD 93.37 K	Dec. 31, 2023	USD 0.78	5.47%	Sweden
41	Alzinova AB (publ) 41 ALZ.ST	USD 4.15 K	Dec. 31, 2023	USD 0.29	0.68%	Sweden
42	Modus Therapeutics Holding AB (publ) 42 MODTX.ST	USD 197.40	Dec. 31, 2023	USD 0.13	-6.51%	Sweden
43	Flowscape Technology AB (publ) 43 FLOWS.ST	USD -30.10 K	Dec. 31, 2023	USD 0.28	6.05%	Sweden
44	Corline Biomedical AB 44 CLBIO.ST	USD -166.41 K	Dec. 31, 2023	USD 0.84	-0.17%	Sweden
45	New Nordic Healthbrands AB (publ) 45 NNH.ST	USD -191.87 K	Dec. 31, 2023	USD 1.35	-1.92%	Sweden
46	Sprint Bioscience AB (publ) 46 SPRINT.ST	USD -205.30 K	Dec. 31, 2023	USD 0.14	1.34%	Sweden
47	Ellen AB (publ) 47 ELN.ST	USD -291.22 K	Dec. 31, 2023	USD 0.09	1.68%	Sweden
48	Promimic AB (publ) 48 PRO.ST	USD -363.61 K	Dec. 31, 2023	USD 1.88	0.68%	Sweden
49	Pila Pharma AB (publ) 49 PILA.ST	USD -869.79 K	Dec. 31, 2023	USD 0.39	2.53%	Sweden
50	Aptahem AB (publ) 50 APTA.ST	USD -987.91 K	Dec. 31, 2023	USD 0.11	1.51%	Sweden

1 2 3

Frequently Asked Questions

Which Pharmaceuticals company in Sweden has the highest EBITDA ?

The Pharmaceuticals company in Sweden with the highest EBITDA is Essity AB (publ) (Stockholm Stock Exchange: ESSITY-B.ST) at USD 2.06 B.
Which Pharmaceuticals company in Sweden has the lowest EBITDA ?

The Pharmaceuticals company in Sweden with the lowest EBITDA is Vitrolife AB (publ) (Stockholm Stock Exchange: VITR.ST) at USD -314.36 M.

What are the top 10 Pharmaceuticals companies in Sweden by EBITDA ?

The top 10 Pharmaceuticals companies in Sweden by EBITDA are Essity AB (publ), Swedish Orphan Biovitrum AB (publ), Lifco AB (publ), Getinge AB (publ), Elekta AB (publ), Medicover AB (publ), Arjo AB (publ), AddLife AB (publ), Nolato AB (publ) and Vimian Group AB (publ).
What are the bottom 10 Pharmaceuticals companies in Sweden by EBITDA ?

The bottom 10 Pharmaceuticals companies in Sweden by EBITDA are Vitrolife AB (publ), Hansa Biopharma AB (publ), Egetis Therapeutics AB (publ), Vicore Pharma Holding AB (publ), BioInvent International AB (publ), Cantargia AB (publ), Oncopeptides AB (publ), SynAct Pharma AB, IRLAB Therapeutics AB (publ) and Xspray Pharma AB (publ).